- Home
- SNOA vs TCRT Comparison
SNOA vs TCRT Comparison
Compare SNOA & TCRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNOA
- TCRT
- Stock Information
- Founded
- SNOA 1999
- TCRT 1998
- Country
- SNOA United States
- TCRT United States
- Employees
- SNOA N/A
- TCRT N/A
- Industry
- SNOA Biotechnology: Pharmaceutical Preparations
- TCRT Biotechnology: Pharmaceutical Preparations
- Sector
- SNOA Health Care
- TCRT Health Care
- Exchange
- SNOA Nasdaq
- TCRT Nasdaq
- Market Cap
- SNOA 6.5M
- TCRT 7.0M
- IPO Year
- SNOA 2007
- TCRT N/A
- Fundamental
- Price
- SNOA $3.76
- TCRT $2.52
- Analyst Decision
- SNOA
- TCRT
- Analyst Count
- SNOA 0
- TCRT 0
- Target Price
- SNOA N/A
- TCRT N/A
- AVG Volume (30 Days)
- SNOA 53.7K
- TCRT 1.3M
- Earning Date
- SNOA 11-04-2025
- TCRT 11-14-2025
- Dividend Yield
- SNOA N/A
- TCRT N/A
- EPS Growth
- SNOA N/A
- TCRT N/A
- EPS
- SNOA N/A
- TCRT N/A
- Revenue
- SNOA $16,937,000.00
- TCRT $6,000.00
- Revenue This Year
- SNOA $23.00
- TCRT $5,680,500.00
- Revenue Next Year
- SNOA $24.59
- TCRT N/A
- P/E Ratio
- SNOA N/A
- TCRT N/A
- Revenue Growth
- SNOA 25.02
- TCRT N/A
- 52 Week Low
- SNOA $1.75
- TCRT $1.31
- 52 Week High
- SNOA $6.92
- TCRT $6.20
- Technical
- Relative Strength Index (RSI)
- SNOA 43.03
- TCRT 42.22
- Support Level
- SNOA $3.73
- TCRT $2.62
- Resistance Level
- SNOA $4.01
- TCRT $2.82
- Average True Range (ATR)
- SNOA 0.22
- TCRT 0.18
- MACD
- SNOA -0.00
- TCRT -0.06
- Stochastic Oscillator
- SNOA 44.32
- TCRT 1.32
About SNOA Sonoma Pharmaceuticals Inc.
Sonoma Pharmaceuticals Inc is a specialty pharmaceutical company operating in the United States. It is engaged in identifying, developing, and commercializing differentiated therapies for patients living with chronic skin conditions. The company focuses on the development and commercialization of therapeutic solutions in medical dermatology to treat skin conditions, such as acne, atopic dermatitis, and scarring. The key products of the company are Celacyn, Ceramax Skin Barrier Cream, Mondoxyne, Alevicyn, SebuDerm, Microcyn, and Microcyn which are available for various skin treatments such as scars, itchy skin, minor skin irritations, rashes, and others. The company derives revenue from the sale of products in the United States, Latin America, Europe, Asia, and other countries.
About TCRT Alaunos Therapeutics Inc.
Alaunos Therapeutics Inc is a clinical-stage cellular immuno-oncology company dedicated to the treatment of solid tumors through adoptive TCR-T cell therapy. It strikes cancer at its core by engineering cell therapies that target Neoantigens arising from genomic mutations. It has a single reportable and operating segment related to biopharmaceutical research and development.